This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 46592581
Submitted by lobbyist on: April 17, 2019 12:31:34 PM
Accepted by Registrar on: May 14, 2019 11:02:13 AM
Designated Filer Information
| Yuceland, Gamze |
| 2201 Bristol Suite 700 | |
|
Oakville, ON, L6H 0J8
|
905-469-9333 |
| Canada |
Organization Information
| Takeda Canada Inc. |
| Takeda is a global pharmaceutical leader founded by Chobei Takeda in 1781 in Osaka, Japan. For over 237 years, we've aimed to make an impact on patients' lives by translating science into life-changing medicines. Our commitment to bringing better health and brighter futures to people around the world is built on a sustainable portfolio of innovative medicines |
| 2201 Bristol Suite 700 | |
|
Oakville, ON, L6H 0J8
|
905-469-9333 |
| Canada |
Relevant Affiliates
Government or Government Agency Funding
Other Controlling or Directing Interests
| Business Name | Mailing Address | Contact Information |
|---|---|---|
| Takeda Pharmaceutical Company Limited |
Takeda Global Headquarters 1-1 Nihonbashi-Honcho 2-Chrome, Chuo-Ku
Tokyo, Japan |
Phone: |
Active Registration Period
| April 17, 2019 | |
| October 17, 2019 |
Organization's In-House Lobbyists
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Economic Development and Trade
Awarding, amendment or termination of a contract, grant or financial benefit
Product education on Takeda oncology and IBD products, including Entyvio, Ninlaro and Alunbrig, related to unique MoA and delivery, clinical and economic value, and how these products address unmet patient needs and contribute to the health of Albertans. Partnering with BioAlberta, Economic and Trade Development, in support of projects related to real-world evidence generation to address gaps in data in one or more of the following therapeutic areas: neurosciences, gastroenterology, oncology as well as rare diseases for therapeutic areas.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Chow, George | Minister of State for Trade | April 17, 2019 |
| Minister | Dix, Adrian | Minister of Health | April 17, 2019 |
| Minister | Fleming, Rob | Minister of Education | April 17, 2019 |
Education
Awarding, amendment or termination of a contract, grant or financial benefit
Product education on Takeda oncology and IBD products, including Entyvio, Ninlaro and Alunbrig, related to unique MoA and delivery, clinical and economic value, and how these products address unmet patient needs and contribute to the health of Albertans. Partnering with BioAlberta, Economic and Trade Development, in support of projects related to real-world evidence generation to address gaps in data in one or more of the following therapeutic areas: neurosciences, gastroenterology, oncology as well as rare diseases for therapeutic areas.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Chow, George | Minister of State for Trade | April 17, 2019 |
| Minister | Dix, Adrian | Minister of Health | April 17, 2019 |
| Minister | Fleming, Rob | Minister of Education | April 17, 2019 |
Health
Awarding, amendment or termination of a contract, grant or financial benefit
Product education on Takeda oncology and IBD products, including Entyvio, Ninlaro and Alunbrig, related to unique MoA and delivery, clinical and economic value, and how these products address unmet patient needs and contribute to the health of Albertans. Partnering with BioAlberta, Economic and Trade Development, in support of projects related to real-world evidence generation to address gaps in data in one or more of the following therapeutic areas: neurosciences, gastroenterology, oncology as well as rare diseases for therapeutic areas.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Chow, George | Minister of State for Trade | April 17, 2019 |
| Minister | Dix, Adrian | Minister of Health | April 17, 2019 |
| Minister | Fleming, Rob | Minister of Education | April 17, 2019 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Economic Development and Trade
Awarding, amendment or termination of a contract, grant or financial benefit
Product education on Takeda oncology and IBD products, including Entyvio, Ninlaro and Alunbrig, related to unique MoA and delivery, clinical and economic value, and how these products address unmet patient needs and contribute to the health of Albertans. Partnering with BioAlberta, Economic and Trade Development, in support of projects related to real-world evidence generation to address gaps in data in one or more of the following therapeutic areas: neurosciences, gastroenterology, oncology as well as rare diseases for therapeutic areas.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Chow, George | Minister of State for Trade | April 17, 2019 |
| Minister | Dix, Adrian | Minister of Health | April 17, 2019 |
| Minister | Fleming, Rob | Minister of Education | April 17, 2019 |
Education
Awarding, amendment or termination of a contract, grant or financial benefit
Product education on Takeda oncology and IBD products, including Entyvio, Ninlaro and Alunbrig, related to unique MoA and delivery, clinical and economic value, and how these products address unmet patient needs and contribute to the health of Albertans. Partnering with BioAlberta, Economic and Trade Development, in support of projects related to real-world evidence generation to address gaps in data in one or more of the following therapeutic areas: neurosciences, gastroenterology, oncology as well as rare diseases for therapeutic areas.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Chow, George | Minister of State for Trade | April 17, 2019 |
| Minister | Dix, Adrian | Minister of Health | April 17, 2019 |
| Minister | Fleming, Rob | Minister of Education | April 17, 2019 |
Health
Awarding, amendment or termination of a contract, grant or financial benefit
Product education on Takeda oncology and IBD products, including Entyvio, Ninlaro and Alunbrig, related to unique MoA and delivery, clinical and economic value, and how these products address unmet patient needs and contribute to the health of Albertans. Partnering with BioAlberta, Economic and Trade Development, in support of projects related to real-world evidence generation to address gaps in data in one or more of the following therapeutic areas: neurosciences, gastroenterology, oncology as well as rare diseases for therapeutic areas.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Chow, George | Minister of State for Trade | April 17, 2019 |
| Minister | Dix, Adrian | Minister of Health | April 17, 2019 |
| Minister | Fleming, Rob | Minister of Education | April 17, 2019 |